I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 33% ± 13% | |
| natural killer cell | 6 studies | 18% ± 2% | |
| GABAergic neuron | 5 studies | 28% ± 18% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 5 studies | 19% ± 2% | |
| endothelial cell | 5 studies | 20% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
| astrocyte | 4 studies | 28% ± 11% | |
| interneuron | 4 studies | 31% ± 15% | |
| oligodendrocyte precursor cell | 4 studies | 42% ± 13% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 17% ± 1% | |
| pancreatic A cell | 3 studies | 17% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 23% ± 1% | |
| non-classical monocyte | 3 studies | 22% ± 5% | |
| epithelial cell | 3 studies | 34% ± 10% | |
| fibroblast | 3 studies | 23% ± 4% | |
| ciliated cell | 3 studies | 22% ± 1% | |
| basal cell | 3 studies | 25% ± 6% | |
| glutamatergic neuron | 3 studies | 35% ± 12% | |
| neuron | 3 studies | 26% ± 5% | |
| gamma-delta T cell | 3 studies | 22% ± 6% | |
| double negative thymocyte | 3 studies | 21% ± 6% |
